Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Regencell Bioscience Holdings Limited before investing.

In this article, we go over a few key elements for understanding Regencell Bioscience Holdings Limited’s stock price such as:

• Regencell Bioscience Holdings Limited’s current stock price and volume
• Why Regencell Bioscience Holdings Limited’s stock price changed recently
• Upgrades and downgrades for RGC from analysts
• RGC’s stock price momentum as measured by its relative strength

About Regencell Bioscience Holdings Limited (RGC)

Before we jump into Regencell Bioscience Holdings Limited’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Want to learn more about Regencell Bioscience Holdings Limited’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Regencell Bioscience Holdings Limited.

Regencell Bioscience Holdings Limited’s Stock Price as of Market Close

As of December 02, 2025, 4:00 PM, CST, Regencell Bioscience Holdings Limited’s stock price was $12.340.

Regencell Bioscience Holdings Limited is up 3.26% from its previous closing price of $11.950.

During the last market session, Regencell Bioscience Holdings Limited’s stock traded between $11.740 and $14.180. Currently, there are approximately 494.49 million shares outstanding for Regencell Bioscience Holdings Limited.

Regencell Bioscience Holdings Limited’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Regencell Bioscience Holdings Limited Stock Price History

Regencell Bioscience Holdings Limited’s (RGC) price is currently up 7.03% so far this month.

During the month of December, Regencell Bioscience Holdings Limited’s stock price has reached a high of $14.180 and a low of $10.500.

Over the last year, Regencell Bioscience Holdings Limited has hit prices as high as $83.600 and as low as $0.093. Year to date, Regencell Bioscience Holdings Limited’s stock is up 9392.31%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Regencell Bioscience Holdings Limited Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 01, 2025, there were analysts who downgraded Regencell Bioscience Holdings Limited’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Regencell Bioscience Holdings Limited’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Regencell Bioscience Holdings Limited’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Regencell Bioscience Holdings Limited (RGC) by visiting AAII Stock Evaluator.

Relative Price Strength of Regencell Bioscience Holdings Limited

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 01, 2025, Regencell Bioscience Holdings Limited has a weighted four-quarter relative price strength of 3598.00%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Regencell Bioscience Holdings Limited is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Regencell Bioscience Holdings Limited Stock Price: Bottom Line

As of December 2, 2025, Regencell Bioscience Holdings Limited’s stock price is $12.340, which is up 3.26% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Regencell Bioscience Holdings Limited stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.